| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
|---|---|
| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
| 131I | radioactive Iodine(used in Thyroid uptake, Liver & Kidney Scans & Treatment of malignant & nonmalig... |
| CHRONIC | chronic disease, rheumatoid arthritis, neoplasms, infections, cryoglobulinemia [conditions in which ... |
| CWEQ | conditions of work effectiveness scale |
| ACSC | Ambulatory Care Sensitive Conditions |
|---|
| nonpermissive cell | <cell biology> Originally a cell of a tissue type or species that does not permit replication of a particular virus. Early stages of the virus cycle may be possible in such a cell, that in the case of tumour viruses may become transformed. Now used in a more general sense, of agents and treatments other than viruses. (18 Nov 1997) |
|---|---|
| precancerous conditions | Pathological processes that tend eventually to become malignant. (12 Dec 1998) |
| saline conditions | Soils or waters that are high in salt content, that is, more than 0.5 parts per thousand (=0.05% salinity). Usually sodium chloride (NaCl) is the predominant salt, but some areas have high concentrations of sulphates, carbonates, and bicarbonates, as well. Habitats are commonly subdivided on the basis of total salt content. (09 Oct 1997) |
| social conditions | The state of society as it exists or in flux. While it usually refers to society as a whole in a specified geographical or political region, it is applicable also to restricted strata of a society. (12 Dec 1998) |
| thermonuclear conditions | <radiobiology> Achievement of an adequately confined plasma, having temperature and density sufficiently high to yield significant release of energy from fusion reactions. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|